The latest oncology news listed by date, covering all clinical focus areas, tumour types and more
ASCO 2024: Novel CAR T cell therapy obe-cel yields strong remission rates in adults with relapsed or refractory B-ALL
The novel anti-CD19 autologous chimeric antigen receptor (CAR) T cell therapy obecabtagene autoleucel (obe-cel) achieved durable remissions…